Getting R&D Right: NASEM Panel Weighs Strategies To Match Innovation With Disease Burden
Executive Summary
A US National Academy of Sciences, Engineering and Medicine panel is considering whether biomedical innovation is aligned with public health needs. The resulting report could impact FDA and federal policy on rare disease and research and development incentives.